Myanmar pharmaceutical market. 5 Myanmar Pharmaceutical Mar

Myanmar pharmaceutical market. 5 Myanmar Pharmaceutical Market Trends. This value is lower than that of most of the ASEAN countries, placing Myanmar below even Singapore in terms of absolute pharmaceutical market size, despite its much larger population (60mn versus 5mn). 6 Myanmar Pharmaceutical Market, By Types. page 1 Myanmar's pharmaceutical industry is experiencing slow growth, driven by rising demand for affordable medicines. 9. Oct 2, 2013 · Health Intelligence Asia, “Healthcare in Myanmar 2013—Myanmar Pharmaceutical Market & Devices Market Survey Report,” accessed Sept. 9, 2013. 3 Market Restraints. Apr 1, 2012 · This document provides an overview of the Myanmar pharmaceutical market, including key statistics such as the estimated $100-120 million market size and leading import countries. Most of pharmaceutical products and drugs are mainly imported from other countries like India, Bangladesh, China, Indonesia, Pakistan, Thailand and Vietnam. Pharmaceutical Companies in Myanmar Myanmar Pharmaceuticals Reports: Our 2025 Myanmar report include trends, statistics, opportunities, sales data, market share, segmentation projections on the Pharmaceuticals market. 4. About the Author Jane Wan is a freelance writer based in Singapore. 56m in 2025. gov Myanmar imports about 80 percent of medicines from other countries. 1 billion by 2023. 52m. Definition: Pharmacies are physical or digital places where mainly pharmaceuticals and medical Apr 25, 2016 · Pharmaceuticals market . According to a local market research agency, total drug spending in Myanmar has increased by 11 percent every year, with the value of the drug market expected to reach $1. 00m. 1 Myanmar Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2031F. 6. Definition: The Pharmaceuticals market covers remedies used to cure, treat Myanma Pharmaceutical Industrial Enterprise (MPIE; Burmese: မြန်မာ့ဆေးဝါးလုပ်ငန်း) is a state-owned enterprise (SOE) under the Ministry of Industry that conducts R&D, manufacturing and distribution for over 200 essential pharmaceuticals. [2] Market Overview Country's pharmaceutical market is valued at USD 456 Million in 2017. This document provides an overview of the Myanmar pharmaceutical market, including key statistics such as the estimated $100-120 million market size and leading import countries. Myanmar’s pharmaceutical market has attracted investors with the sector projected to be worth $100 to $120 million despite its relatively small population of approximately 60 million people. Looking ahead to 3. However, these values are lower than most ASEAN nations including Singapore whose population is one tenth that of Myanmar. It also outlines the regulatory landscape, describing the registration and import procedures for pharmaceutical products as well as detailing the various government Myanmar: In Myanmar, the Pharmacies market is forecasted to achieve a revenue of US$897. Indian companies like Sun Pharmaceuticals, Dr Reddy’s, Wockhardt and Hetro are enjoying significant market share in Myanmar’s local pharmaceutical market. Definition: The Over-the-Counter Pharmaceuticals market includes non-prescription medications The formost and largest Pharmaceutical Factory in Myanmar interms of production capacity. India is a key partner for Myanmar in the pharmaceutical trade. 2 Myanmar Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F Myanmar: In 2025, the revenue in the OTC Pharmaceuticals market in Myanmar amounts to US$293. 10 Myanmar Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F. The domestic manufacturing sector remains limited, with the market relying heavily on imports, though government initiatives aim to expand local production and improve regulatory standards. The factory was founded in 1954 and Producing-Wide range of pharmaceutical products including Tablet, Capsule, Oral Liquids, Ointments, Lotion, Sterile Products, Injection, Infusion and Biological Products (Vaccine and Snake Ant ivenom). Business Monitor International, “Myanmar Pharmaceuticals and Healthcare Report Q3 2013", accessed Sept. According to market research agencies the total pharmaceutical expenditure in Myanmar has been growing at 11-12% per annum, and has increased from USD 390 million in 2014 to USD 440 million in 2015. Myanmar Pharmaceutical and Medical Device Manufacturer Association (MPMDMA) was established in April 2018 with the permission from the Ministry of Planning and Finance in their announcement letter (SaBa/Si/Khant - 1/1 (3124/2018)) dated 26th April 2018 with the official registration number 187/2018/19(AhThin). [1] MPIE has a domestic market share ranging between 3% and 10%. It also outlines the regulatory landscape, describing the registration and import procedures for pharmaceutical products as well as detailing the various government Oct 1, 2013 · International pharmaceutical companies are flocking into Myanmar to explore business opportunities in the country. . Jul 4, 2018 · The pharmaceutical market in Myanmar is mainly depended on the foreign imported medicines and drugs as Myanmar’s domestic pharmaceutical industry is still small. Foreign investment has been constrained by political and economic instability, but 8 Myanmar Pharmaceuticals Market Key Performance Indicators. 9 Myanmar Pharmaceuticals Market - Opportunity Assessment. 1 Impact Analysis. 1 billion by 2030, growing at a Our Profile. Myanmar – Pharmaceutical Retail Market Snapshot (2025) Market Size & Growth: The pharmaceutical retail market in Myanmar is projected to reach approximately USD 1. 2. Myanmar: In 2025, the projected revenue in the Pharmaceuticals market in Myanmar is expected to reach US$283. Indian generic drug manufacturers are also hugely popular and accepted in Myanmar. 4 Myanmar Pharmaceutical Market Dynamics. 2 Market Drivers. 1 Myanmar Pharmaceutical Market, By Prescription Type See full list on trade. fetxpqyy woluc vmkz jbgkktt isxv wmdzu mzxnsay cbm qws jhp